Two-year outcomes of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab

被引：0
|
作者：
Izawa, Hidetomo [1 ]
Azuma, Keiko [1 ]
Matsuda, Aya [2 ]
Shimizu, Kimiko [1 ]
Tan, Xue [1 ]
Inoue, Tatsuya [1 ]
Obata, Ryo [1 ]
机构：
[1] Univ Tokyo Hosp, Bunkyo Ku, Tokyo, Japan
[2] Toranomon Gen Hosp, Tokyo, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
879
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab
    Freund, K. Bailey
    Hoang, Quan V.
    Saroj, Namrata
    Thompson, Desmond
    [J]. OPHTHALMOLOGY, 2015, 122 (09) : 1802 - 1810
  • [42] INTRAVITREAL AFLIBERCEPT FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION UNRESPONSIVE TO RANIBIZUMAB THERAPY
    Sarao, Valentina
    Parravano, Mariacristina
    Veritti, Daniele
    Arias, Luis
    Varano, Monica
    Lanzetta, Paolo
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (04): : 770 - 777
  • [43] Cost Comparison of Intravitreal Aflibercept With Bevacizumab and Ranibizumab for the Treatment of Wet Age-Related Macular Degeneration
    Shaikh, Adeel H.
    Toussaint, Brian W.
    Miller, Daniel M.
    Petersen, Michael R.
    Foster, Robert E.
    Riemann, Christopher D.
    Hutchins, Robert K.
    Sisk, Robert A.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (01): : 62 - 66
  • [44] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    [J]. International Ophthalmology, 2017, 37 : 1205 - 1214
  • [45] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [46] Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
    Urban, Beata
    Szwabowicz, Magdalena
    Bakunowicz-Lazarczyk, Alina
    [J]. JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [47] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Park, Dae Hyun
    Sun, Hae Jung
    Lee, Sung Jin
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (05) : 1205 - 1214
  • [48] Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy
    Sarao, Valentina
    Veritti, Daniele
    Arias, Luis
    Lanzetta, Paolo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [49] Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept
    Kaya, F.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (10): : 832 - 838
  • [50] Visual and Anatomical Outcomes of Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration
    Gharbiya, Magda
    Iannetti, Ludovico
    Parisi, Francesco
    De Vico, Umberto
    Mungo, Maria Laura
    Marenco, Marco
    [J]. BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345